U.S. President Donald Trump announced on Friday that the federal government is taking steps to expand access to GLP-1 medications for seniors enrolled in Medicare, with coverage expected to begin on July 1.

If passed, the law would increase oversight of private plans and curb practices lawmakers say delay or even deny care for seniors.

Medicare may expand coverage for GLP-1 drugs like Wegovy in 2026. Learn who may qualify, what the program includes, and how it could affect your plan choices.

Americans enrolled in Medicare Advantage health plans should expect to see fewer extra benefits like gym memberships and vision and dental coverage next ​year, investors and industry experts say.

THE VILLAGES, Florida, ‌May ‌1 () - U. ​President Donald Trump said ‌on ⁠Friday the government ⁠is moving ​to ​make ​GLP-1 ‌weight-loss and diabetes drugs available ‌to ​seniors ​enrolled ​in ‌Medicare from July ​1.

Bruine de Bruin is director of the Behavioral Sciences and Policy Initiative at the USC Schaeffer Institute for Public Policy and Government Service. Blum is a nonresident senior scholar at the USC Schaeffer Institute and the former principal deputy ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the popular weight-loss drugs

Discover the top Medigap insurance providers, including AARP/UnitedHealthcare, Anthem, and State Farm. Compare plans for coverage, pricing, and customer satisfaction.

Proponents of medicinal hemp and medical marijuana are generally pleased with the pilot program launched in April by CMS to allow certain Medicare enrollees access to hemp-derived products.

Margin improvement and MA member retention are doable, as are top-quartile star-rating results in 2028, company says.

Senator Maria Cantwell has called on HHS to overhaul the Wasteful and Inappropriate Service Reduction (WISeR) Model.